Artificial Intelligence in Drug Discovery Market Intelligence Report - Global Forecast to 2027

Artificial Intelligence in Drug Discovery Market Intelligence Report - Global Forecast to 2027

The Global Artificial Intelligence in Drug Discovery Market is projected to reach USD 2,760.77 million by 2027 from USD 701.05 million in 2021, at a CAGR 25.66% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Artificial Intelligence in Drug Discovery Market size was estimated at USD 286.37 million in 2021 and expected to reach USD 351.96 million in 2022, at a CAGR 25.24% to reach USD 1,105.52 million by 2027.
• The Asia-Pacific Artificial Intelligence in Drug Discovery Market size was estimated at USD 160.88 million in 2021 and expected to reach USD 203.34 million in 2022, at a CAGR 26.39% to reach USD 656.12 million by 2027.
• The Europe, Middle East & Africa Artificial Intelligence in Drug Discovery Market size was estimated at USD 253.79 million in 2021 and expected to reach USD 315.02 million in 2022, at a CAGR 25.65% to reach USD 999.12 million by 2027.

Market Segmentation & Coverage:

The report on artificial intelligence in drug discovery identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the artificial intelligence in drug discovery to forecast the revenues and analyze the trends in each of the following sub-markets:

Offering:

• Services
• Software

Application:

• Cardiovascular Disease
• Immuno-Oncology
• Metabolic Diseases
• Neurodegenerative Diseases

End User:

• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Research Centers and Academic & Government Institutes

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Aria Pharmaceuticals
• Atomwise, Inc.
• BenevolentAI Limited
• BioSymetrics Inc.
• Cloud Pharmaceuticals, Inc.
• Cyclica Inc.
• Deep Genomics Incorporated
• Envisagenics, Inc.
• Exscientia
• Insitro, Inc.
• International Business Machines Corporation
• Microsoft Corporation
• Novartis AG
• NVIDIA Corporation
• Owkin, Inc.
• Verge Genomics Inc.
• XtalPi Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 701.05 million

Estimated Year Value: USD 870.33 million

Forecast Year Value: USD 2,760.77 million

CAGR (%): 25.66%.

Please Note: PDF & Excel + Online Access - 1 Year